Keyword Analysis & Research: anticoagulation after tavr

nih.gov

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7203879/

Apr 23, 2020 · Finally, among 220 patients otherwise not requiring OAC, the open-label Anticoagulant Versus Dual Antiplatelet Therapy for Preventing Leaflet Thrombosis and … Author: Antonio Greco, Davide Capodanno Publish Year: 2020

Author: Antonio Greco, Davide Capodanno

Publish Year: 2020

DA: 10 PA: 26 MOZ Rank: 41

acc.org

https://www.acc.org/latest-in-cardiology/articles/2014/07/18/15/35/anticoagulation-in-tavr

Few small studies have specifically addressed the use of anticoagulation in TAVR. A 2013 study by Czerwinska-Jelonkiewicz et al. assessed bleeding complications in 83 patients after TAVR in the context of antithrombotic management.51 After TAVR, 10% of patients were given aspirin, clopidogrel, and a VKA (triple therapy), 18.7% were given aspirin pl...

Few small studies have specifically addressed the use of anticoagulation in TAVR. A 2013 study by Czerwinska-Jelonkiewicz et al. assessed bleeding complications in 83 patients after TAVR in the context of antithrombotic management.51 After TAVR, 10% of patients were given aspirin, clopidogrel, and a VKA (triple therapy), 18.7% were given aspirin pl...

DA: 4 PA: 65 MOZ Rank: 56

nih.gov

https://pubmed.ncbi.nlm.nih.gov/33040213/

This finding is less prevalent in patients on anticoagulation and resolves following initiation of anticoagulation. Routine anticoagulation after TAVR in high-surgical-risk patients was … Author: Tarun Chakravarty, Hasan Jilaihawi, Angelo de la Rosa, Raj Makkar Publish Year: 2020

Author: Tarun Chakravarty, Hasan Jilaihawi, Angelo de la Rosa, Raj Makkar

Publish Year: 2020

DA: 42 PA: 27 MOZ Rank: 58

acc.org

https://www.acc.org/latest-in-cardiology/ten-points-to-remember/2019/11/22/15/22/adjunctive-antithrombotic-therapy-for-as

Nov 22, 2019 · Atrial fibrillation is associated with both stroke and bleeding events following TAVR. In patients with an indication for anticoagulation therapy, aspirin or clopidogrel …

DA: 50 PA: 77 MOZ Rank: 76

scitechnol.com

https://www.scitechnol.com/peer-review/anticoagulation-in-patients-with-atrial-fibrillation-after-a-transcatheter-aortic-valve-replacement-a-review-bDda.php?article_id=10927

After TAVR, AF is the most common reason a patient will require anticoagulation. A metaanalysis concluded that AF is common in TAVR population with 33.1% of the overall … Author: Garly Saint Croix, Jason Galo, Sharde Chambers, Nirat Beohar Publish Year: 2020

Author: Garly Saint Croix, Jason Galo, Sharde Chambers, Nirat Beohar

Publish Year: 2020

DA: 44 PA: 63 MOZ Rank: 97

nejm.org

https://www.nejm.org/doi/full/10.1056/NEJMoa1915152

Mar 29, 2020 · Randomization and Follow-up. TAVI denotes transcatheter aortic-valve implantation. From December 2013 through August 2018, a total of 326 patients who were …

DA: 59 PA: 15 MOZ Rank: 60

nih.gov

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8880334/

Feb 11, 2022 · Conclusion: For patients with an indication for oral anticoagulation after TAVR, NOACs seem to be associated with noninferior outcomes compared with VKA therapy. …

DA: 95 PA: 52 MOZ Rank: 81

nih.gov

https://pubmed.ncbi.nlm.nih.gov/31466616/

In the short term, early AC after bioprosthetic AVR did not result in adverse clinical events, did not significantly affect aortic valve hemodynamics (aortic valve gradients or area), and was …

DA: 94 PA: 29 MOZ Rank: 7

uptodate.com

https://www.uptodate.com/contents/transcatheter-aortic-valve-implantation-antithrombotic-therapy

Aug 03, 2021 · Post-TAVI antithrombotic therapy varies depending upon the following factors ( algorithm 1 ): Presence of a concurrent indication for anticoagulation (such as atrial …

DA: 24 PA: 36 MOZ Rank: 4

ahajournals.org

https://www.ahajournals.org/doi/10.1161/CIRCINTERVENTIONS.118.007411

GALILEO trial (The Global Study Comparing a Rivaroxaban-Based Antithrombotic Strategy to an Antiplatelet-Based Strategy After Transcatheter Aortic Valve Replacement to Optimize …

DA: 3 PA: 73 MOZ Rank: 13